Surescripts, the nation’s leading health information network, acquired ActiveRADAR, a clinical intelligence company that identifies therapeutic alternatives for prescriptions.

Surescripts是美国领先的健康信息网络，收购了ActiveRADAR，这是一家临床情报公司，旨在确定处方的治疗方案。

“We are always looking for ways to broaden our impact on patients and the people who care for them,” explained Frank Harvey, Chief Executive Officer at Surescripts. “Our acquisition of ActiveRADAR underscores our commitment to optimizing our network solutions with even more comprehensive clinical and cost data available at the point of prescribing.

Surescripts首席执行官弗兰克·哈维（Frank Harvey）解释说：“我们一直在寻找扩大对患者和照顾他们的人的影响的方法。“我们收购ActiveRADAR强调了我们致力于优化我们的网络解决方案，并在处方时提供更全面的临床和成本数据。

Together, we can make it simpler and faster to get patients started on the best medication for them.”.

总之，我们可以让患者开始为他们提供最佳药物，从而使其更简单，更快速。”。

ActiveRADAR (formerly known as RxTE Health) offers evidence-based, formulary-specific, and medically accepted use-specific therapeutic alternatives, along with corresponding dosage strengths, quantities, and plan-specific patient and health plan costs. ActiveRADAR’s Clinical Catalogue covers more than 165 therapeutic categories, including more than 30 specialty drug categories and more than 33,000 drug pairs, as well as both clinical and economic value on medication alternatives, and has been shown to reduce costs for employers and employees by 15 to 20%..

ActiveRADAR（以前称为RxTE Health）提供基于证据，特定处方和医学接受的使用特定治疗方案，以及相应的剂量强度，数量和计划特定的患者和健康计划成本。Active Radar的临床目录涵盖165多个治疗类别，包括30多种特种药物类别和33000多种药物对，以及药物替代品的临床和经济价值，并已被证明可将雇主和员工的成本降低15至20%。。

“We are very pleased to have reached this agreement which will allow ActiveRADAR to have a direct impact on improving medication adherence as well as patient and provider engagement,” said Dave Teckman, former Chief Executive Officer at ActiveRADAR. “Our analytical processes target and prioritize savings opportunities to minimize member disruption and maximize savings, which ultimately improves the patient experience and takes waste and costs out of the system.”.

“我们非常高兴地达成了这项协议，这将使ActiveRADAR能够直接影响改善药物依从性以及患者和提供者的参与度，”ActiveRADAR前首席执行官Dave Teckman说。“我们的分析流程的目标是并优先考虑储蓄机会，以最大限度地减少成员中断并最大限度地节省开支，最终改善患者体验并将浪费和成本从系统中排出“。

“Providing faster access to insights and optimizing the value delivered by our data are two of our biggest priorities, so we’re thrilled to have the ActiveRADAR team joining Surescripts,” said Dr. Lynne Nowak, Chief Data & Analytics Officer at Surescripts. “With access to their extensive catalog of therapeutic alternatives data, we can reduce drug spend and help provide more alternatives when deploying prescription pricing information to providers.”.

Surescripts的首席数据和分析官员Lynne Nowak博士说：“提供更快的洞察力访问和优化我们的数据所提供的价值是我们最大的优先事项之一，因此我们很高兴有ActiveRADAR团队加入Surescripts。“通过获取广泛的治疗替代品数据目录，我们可以减少药物支出，并在向供应商部署处方定价信息时帮助提供更多替代方案。”。

Surescripts connects more than 2 million healthcare professionals and providers with plan-level formulary details to support more informed conversations for a better patient experience. In 2022, Surescripts processed 2.34 billion electronic prescriptions filled by pharmacies nationwide, and as of October 2023, more than 777,000 prescribers in the United States use Surescripts Real-Time Prescription Benefit, saving patients an average of $61 on traditional prescriptions and $428 on specialty medications..

Surescripts将200多万医疗保健专业人员和提供者与计划级处方集详细信息联系起来，以支持更明智的对话，从而获得更好的患者体验。2022年，Surescripts处理全国药房填写的23.4亿电子处方，截至2023年10月，美国超过777000名处方医生使用Surescripts实时处方福利，为患者平均节省61美元的传统处方和428美元的专业药物。。

Originally announced November 6th, 2023

最初于2023年11月6日宣布

TagsActiveRADAR Dave Teckman Dr. Lynne Nowak Frank Harvey Health IT Acquisitions Healthcare M&A RxTE Health SureScripts

TagsActiveRADAR Dave Teckman Lynne Nowak博士Frank Harvey Health IT收购医疗保健M＆A RxTE Health SureScripts

Get Fresh Healthcare & IT Stories Delivered Daily

每天提供新鲜的医疗保健和IT故事

Join thousands of your healthcare & HealthIT peers who subscribe to our daily newsletter.

加入数千名订阅我们每日通讯的医疗保健和健康同行。

We respect your privacy and will never sell or give out your contact information

我们尊重您的隐私，绝不会出售或提供您的联系信息